🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: standard or investigator-determined chemotherapy

Found 65 matching trials

A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

PHASE3

Multiple myeloma is a cancer of the plasma cells in the bone marrow. The m...

Status

Recruiting

Location

Infirmary Health - Diagnostic & Medical Clinic (DMC)

Start Date

2026-01-14

Trial ID

NCT06980480

Treatments Being Tested

IGI, 10%

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

PHASE1

This is an open-label, two-part, phase 1-2 dose-finding study designed to d...

Status

Active Not Recruiting

Location

University of California, San Francisco

Start Date

2020-07-01

Trial ID

NCT04478279

Treatments Being Tested

ST101 Temozolomide Radiation

Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin Lymphoma

PHASE2

This phase II trial compares the impact of brentuximab vedotin and nivoluma...

Status

Not Yet Recruiting

Location

Multiple Locations

Start Date

2026-12-04

Trial ID

NCT07572123

Treatments Being Tested

3-Dimensional Conformal Radiation Therapy Autologous Hematopoietic Stem Cell Transplantation Biospecimen Collection Brentuximab Vedotin Computed Tomography High Dose Chemotherapy Intensity-Modulated Radiation Therapy Nivolumab Pembrolizumab Pencil Beam Scanning Positron Emission Tomography Salvage Therapy Scattering Proton Beam Therapy Tomotherapy Uniform Active Scanning Proton Beam Therapy Volume Modulated Arc Therapy

A Multicenter, Prospective, Real-world Study of a Regimen Containing Tucidinostat for Primary Treatment of DLBCL

N/A

This is a prospective, observational, multicenter, cohort study with 400 ne...

Status

Recruiting

Location

No. 197 Ruijin 2nd Road, Huangpu District, Shanghai

Start Date

2025-01-01

Trial ID

NCT06779435

Treatments Being Tested

Low intensity treatment options Conventional immunochemotherapy regimen

Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).

PHASE3

This is a randomized, open-label, multi-center, global, Phase III study to ...

Status

Active Not Recruiting

Location

Research Site

Start Date

2017-06-01

Trial ID

NCT03164616

Treatments Being Tested

Durvalumab Tremelimumab Abraxane + carboplatin Gemcitabine + cisplatin Gemcitabine + carboplatin Pemetrexed + carboplatin Pemetrexed + cisplatin

A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma

PHASE3

This trial will compare tisagenlecleucel to standard of care in adult parti...

Status

Active Not Recruiting

Location

Novartis Investigative Site

Start Date

2023-10-02

Trial ID

NCT05888493

Treatments Being Tested

Tisagenlecleucel Lenalidomide and rituximab (R2) in 28-day cycles for up to 12 cycles.Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone or prednisolone (R-CHOP) in 21-day cycles for 6 to 8 cycles Lymphodepleting chemotherapy Corticosteroids and/or Radiation (Bridging therapy)

A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer

PHASE2

This phase 2 study is a multicenter, randomized, double-blind, placebo-cont...

Status

Completed

Location

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Start Date

2011-12

Trial ID

NCT01505530

Treatments Being Tested

LY2495655 Placebo Standard of Care Chemotherapy

A Study of MR001 Combined With Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) After First-line Therapy

PHASE1

This Phase Ib/IIa study is evaluating the safety, tolerability, pharmacokin...

Status

Recruiting

Location

Beijing Tsinghua Changgung Hospital

Start Date

2025-12-24

Trial ID

NCT07235202

Treatments Being Tested

MR001 Irinotecan Liposome Injection combined with 5-FU/LV Nab-paclitaxel Gemcitabine (GEM)

Personalised Therapy for Metastatic ADPC Determined by Genetic Testing and Avatar Model Generation

PHASE2

This is a multicenter, open label, randomised phase II clinical trial for p...

Status

Unknown

Location

Hospital Universitario de Fuenlabrada

Start Date

2016-05

Trial ID

NCT02795650

Treatments Being Tested

Personalised treatment Treatment chosen per investigator´s judge

Efficacy of Momelotinib Versus Best Available Therapy in Anemic or Thrombocytopenic Subjects With Primary Myelofibrosis (MF), Post-polycythemia Vera MF, or Post-essential Thrombocythemia MF

PHASE3

This study is to determine the efficacy of momelotinib (MMB) versus best av...

Status

Completed

Location

Multiple Locations

Start Date

2014-06-19

Trial ID

NCT02101268

Treatments Being Tested

Momelotinib Best Available Therapy (BAT)

Previous Next